Sobuzoxane
-
Sobuzoxane
structure -
-
CAS No:
98631-95-9
-
Formula:
C22H34N4O10
-
Chemical Name:
Sobuzoxane
-
Synonyms:
Carbonic acid,C,C′-[1,2-ethanediylbis[(2,6-dioxo-4,1-piperazinediyl)methylene]] C,C′-bis(2-methylpropyl) ester;Carbonic acid,1,2-ethanediylbis[(2,6-dioxo-4,1-piperazinediyl)methylene] bis(2-methylpropyl) ester;MST 16;Sobuzoxane
-
CAS No:
Description
Sobuzoxane is an organic molecular entity.|Sobuzoxane is the orally available active prodrug of ICRF-154, a bisdioxopiperazine derivative, with cardioprotective and antineoplastic activities. Like other ICRF compounds, sobuzoxane and its active metabolite ICRF-154 interfere with topoisomerase II activity prior to the formation of intermediate cleavable DNA-enzyme complexes during the catalytic cycle resulting in tumor cell growth inhibition. Furthermore, sobuzoxane chelates metal cations thereby limiting the formation of free radical-generating anthracycline-metal complexes and may prevent anthracycline-induced oxidative damage to cardiac and soft tissues.
Characteristics
152 Ų
1.272±0.06 g/cm3
128-130 °C
664.9±55.0 °C(Predicted)
LD50 in male, female mice, rats (mg/kg): 807, 960, 877, 567 i.p.; 400, 673, 3025, 2821 s.c.; >5 g/kg orally in all species (Tokiwa)
2.75±0.20
Drug Information
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)|Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)
1,2-bis(4-isobutoxycarbonyloxymethyl-3,5-dioxopiperazin-1-yl)ethane
Request for Quotation